Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Feb 04, 2021 1:26pm
125 Views
Post# 32471731

RE:RE:RE:RE:RE:RE:RE:RE:RE:Today’s trading

RE:RE:RE:RE:RE:RE:RE:RE:RE:Today’s tradingWell it seems the company is not moving from the very first step and darn right it is slow!
When the came out with the deal I wondered how many of the new shareholders would stay put?
It looks like a good portion didn't as it seems that lid is still on right?
What exactly did company do to convince these new shareholders not selling for a little profit?
What/where was their contingency plan to convert the traders to investors?
The deal was bad to deal with consequences is even worse. I send an email which was posted here to Leah trying to guide her towards some simple/cost effective  yet helpful sell techniques to mitigate the damage instead of trying their highly successful marketing a total radio silence!!!



FredTheVoice wrote: PALINC,

for you 2, enough is enough ! 

First: everything that JFM will right, even if it was: The snow is white. It will be wrong for you.

Second: its a step by step recovery with something that he is trying to explain, and you cant get it: the market is still in a non-confidence area with TH, (and it will change....slowly) because of the past: and add to that, the sales of Trogarzo......

Third: You are right PALINC, wow ! You are amazing ! And JFM is wrong !!!!

HAPPY ?

FTV. 


<< Previous
Bullboard Posts
Next >>